Enteromed

Enteromed is a UK-based healthcare company specializing in the distribution and clinical development of Enterosgel, an innovative intestinal adsorbent. Enterosgel is a drug-free, organic mineral-based hydrogel designed to treat various gastrointestinal conditions by binding and removing toxins, pathogens, and allergens from the gut. The company focuses on providing effective solutions for Irritable Bowel Syndrome with Diarrhea (IBS-D), acute diarrhea, and chronic digestive disorders. Enteromed's flagship product is clinically proven, notably through the RELIEVE-IBS-D trial, and is widely available across Europe and other international markets.